Status:
COMPLETED
Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Premature Birth of Newborn
Eligibility:
All Genders
Up to 14 years
Phase:
NA
Brief Summary
The purpose of this study is to see if daily massage therapy will help premature infants respond to stress better, as well as improve their growth and neurobehavioral development.
Detailed Description
Optimal postnatal growth and development is essential for the survival and long-term health of infants born premature, however, growth and developmental delays are common. Many factors contribute to p...
Eligibility Criteria
Inclusion
- Premature infants born between 29 4/7 and 32 3/7 weeks gestation by physical exam at birth, and with birth weight, length and head circumference between the 5th and 95th percentiles for gestational age.
Exclusion
- Intrauterine growth less than the 5th or greater than the 95th percentiles for gestational age, congenital anomalies, complex cardiac defects, severe CNS injury, hypothyroidism, inborn errors of metabolism, or inability to establish full enteral feeds by day of life 14.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00722943
Start Date
July 1 2008
End Date
July 1 2011
Last Update
February 8 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Intermountain Medical Center
Murray, Utah, United States, 84107
2
St. Mark's Hospital
Salt Lake City, Utah, United States, 84124
3
University of Utah
Salt Lake City, Utah, United States, 84132